G-CSF-receptor mutations are not the cause of congenital neutropenia but increase the risk of developing acute myeloid leukemia.

被引：0

作者：

Tidow, N ^{[1
]}

Teichmann, B ^{[1
]}

Pilz, C ^{[1
]}

Kasper, B ^{[1
]}

Germeshausen, M ^{[1
]}

Welte, K ^{[1
]}

机构：

[1] HANNOVER MED SCH,DEPT PEDIAT HEMATOL & ONCOL,D-3000 HANNOVER,GERMANY

来源：

EXPERIMENTAL HEMATOLOGY | 1996年 / 24卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：268 / 268

页数：1

共 50 条

[41] Rarity of dominant-negative mutations of the G-CSF receptor in patients with blast crisis of chronic myeloid leukemia or de novo acute leukemia [J].

Carapeti, M ;

SoedeBobok, A ;

Hochhaus, A ;

Sill, H ;

Touw, IP ;

Goldman, JM ;

Cross, NCP .

LEUKEMIA, 1997, 11 (07) :1005-1008

[42] Rarity of dominant-negative mutations of the G-CSF receptor in patients with blast crisis of chronic myeloid leukemia or de novo acute leukemia [J].

M Carapeti ;

A Soede-Bobok ;

A Hochhaus ;

H Sill ;

IP Touw ;

JM Goldman ;

NCP Cross .

Leukemia, 1997, 11 :1005-1008

[43] DISTINCT CYTOPLASMIC DOMAINS OF THE HUMAN G-CSF RECEPTOR DETERMINE PROLIFERATION AND MATURATION SIGNALING - IMPLICATIONS FOR THE DEVELOPMENT OF NEUTROPENIA AND ACUTE MYELOID-LEUKEMIA [J].

TOUW, I ;

VANPAASSEN, M ;

SCHELEN, A ;

HOEFSLOOT, L ;

LOWENBERG, B ;

DONG, F .

BLOOD, 1993, 82 (10) :A185-A185

[44] Flow cytometric G-CSF receptor expression in acute myeloid leukemia and role in G-CSF use at induction chemotherapy [J].

Kutlay, S ;

Beksaç, M ;

Dalva, K ;

Ilhan, O ;

Koç, H ;

Akan, H ;

Özcan, M ;

Konuk, N ;

Uysal, A .

BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) :87-87

[45] Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of poor risk acute myeloid leukemia [J].

Montillo, M ;

Mirto, S ;

Petti, MC ;

Latagliata, R ;

Magrin, S ;

Pinto, A ;

Zagonel, V ;

Mele, G ;

Tedeschi, A ;

Ferrara, F .

AMERICAN JOURNAL OF HEMATOLOGY, 1998, 58 (02) :105-109

[46] Prognostic impact of CSF3R mutations in favorable risk childhood acute myeloid leukemia [J].

Tarlock, Katherine ;

Alonzo, Todd ;

Wang, Yi-Cheng ;

Gerbing, Robert B. ;

Ries, Rhonda E. ;

Hylkema, Tiffany ;

Smith, Jenny L. ;

Maxson, Julia E. ;

Meshinchi, Soheil .

BLOOD, 2020, 135 (18) :1603-1606

[47] Severe congenital neutropenia patients with point mutations in the granulocyte colony-stimulating factor (G-CSF) receptor mRNA express a normal G-CSF receptor protein [J].

Kasper, B ;

Herbst, A ;

Pilz, C ;

Germeshausen, M ;

Tidow, N ;

Hadam, MR ;

Welte, K .

BLOOD, 1997, 90 (07) :2839-2841

[48] Improved survival from granulocyte-colony stimulating factor therapy for congenital neutropenia unmasks predisposition to myelodysplasia and acute myeloid leukemia. [J].

Freedman, MH ;

Bonilla, MA ;

Fier, C ;

Bolyard, AA ;

Scarlatta, D ;

Boxer, LA ;

Brown, S ;

Cham, B ;

Kannourakis, G ;

Kinsey, SE ;

Mori, PG ;

Cottle, T ;

Welte, K ;

Dale, DC .

PEDIATRIC RESEARCH, 1999, 45 (05) :747-747

[49] G-CSF receptor mutations in congenital neutropenia patients predispose not only to development of secondary AML, but also to secondary all [J].

Germeshausen, M ;

Ballmaier, M ;

Tschan, C ;

Zeidler, C ;

Abrahamsen, TG ;

Welte, K .

EXPERIMENTAL HEMATOLOGY, 1999, 27 (07) :71-71

[50] G-CSF receptor mutations in severe congenital neutropenia patients do not abrogate the nuclear translocation of Stat1. [J].

Herbst, A ;

Koster, M ;

Wirth, D ;

Hoxter, M ;

Germeshausen, M ;

Kasper, B ;

Hauser, H ;

Welte, K .

BLOOD, 1997, 90 (10) :3526-3526

← 1 2 3 4 5 →